HMGA2 promotes resistance against paclitaxel by targeting the p53 signaling pathway in colorectal cancer cells
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Medical Scientific Research Foundation of Zhejiang Province, China
- Natural Science Foundation of Ningbo Municipality (2023J153)
This publication has 45 references indexed in Scilit:
- HMGA2 promotes intestinal tumorigenesis by facilitating MDM2‐mediated ubiquitination and degradation of p53The Journal of Pathology, 2018
- Oxidative StressAnnual Review of Biochemistry, 2017
- Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk NeuroblastomaCancer Cell, 2017
- TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics DataHuman Mutation, 2016
- Worldwide burden of colorectal cancer: a reviewUpdates in Surgery, 2016
- Oxidative stress: a concept in redox biology and medicineRedox Biology, 2015
- Multiple Genes of the Renin-Angiotensin System Are Novel Targets of Wnt/β-Catenin SignalingJournal of the American Society of Nephrology, 2015
- HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathwayStem Cell Research, 2013
- HMGA2: A pituitary tumour subtype-specific oncogene?Molecular and Cellular Endocrinology, 2010
- HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer CellsThe American Journal of Pathology, 2009